Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Abiraterone Acetate/therapeutic use"'
Autor:
Caroline S. Clarke, Rachael M. Hunter, Andrea Gabrio, Christopher D. Brawley, Fiona C. Ingleby, David P. Dearnaley, David Matheson, Gerhardt Attard, Hannah L. Rush, Rob J. Jones, William Cross, Chris Parker, J. Martin Russell, Robin Millman, Silke Gillessen, Zafar Malik, Jason F. Lester, James Wylie, Noel W. Clarke, Mahesh K. B. Parmar, Matthew R. Sydes, Nicholas D. James
Publikováno v:
PLOS ONE, 17(6):e0269192. Public Library of Science
Adding abiraterone acetate (AA) plus prednisolone (P) to standard of care (SOC) improves survival in newly diagnosed advanced prostate cancer (PC) patients starting hormone therapy. Our objective was to determine the value for money to the English Na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96c61a2c8647df9bb344a6404851121f
https://doi.org/10.1371/journal.pone.0269192
https://doi.org/10.1371/journal.pone.0269192
Autor:
Thierry Gil, Peter Schatteman, Marylene Clausse, Jan Van Haverbeke, Joanna Van Erps, Jeroen Mebis, Wim Demey, Marika Rasschaert, Dirk Schrijvers, Lionel D'Hondt, Els Everaert, W. Wynendaele, Bertrand Filleul, Sylvie Rottey, Filip Van Aelst, Joanna Vermeij, Fransien Van Hende, Patrick Werbrouck, Jean-Charles Goeminne, Charles Van Praet, Gino Pelgrims, Nicolaas Lumen, Jolanda Verheezen, Jean Pascal Machiels, Denis Schallier
Publikováno v:
Clinical Genitourinary Cancer
Individual patients' survival varies greatly in metastatic castration-resistant prostate cancer. Retrospective analysis of 368 patients treated with docetaxel and starting abiraterone acetate revealed 5 adverse prognostic factors: hemoglobin < 12 g/d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05307a24c7cbd336f7da4e0f7a8dd3be
https://doi.org/10.1016/j.clgc.2017.01.019
https://doi.org/10.1016/j.clgc.2017.01.019